A total of 1.5 million people died from TB in 2020. Worldwide, TB is the second leading infectious killer after COVID-19, above HIV/AIDS.
TB is curable and preventable. WHO recommend the use of X-ray to reduce the screening cost. However, the shortage of radiologists in underserved regions hinders early detection of TB cases.
How AI revolutionizes TB screening: speedy analysis that saves cost
Proven accuracy in high-burden settings
InferRead® DR Chest out-performed expert local radiologists when detecting TB in Bangladesh. • AUC= 84.90% (84.27-85.54) • Halved the number of diagnostic tests required, retaining sensitivity >90%.
InferRead® DR Chest achieved high accuracy AUC=0.854 (0.824-0.884) in a high-HIV/TB population in South Africa. • Achieved a similar performance to the WHO TPP, with around 90% sensitivity and 70.4% specificity, simultaneously.
Compatible with a wide range of X-ray system types
